Lumen Bioscience Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 67

Employees

  • Latest Deal Type
  • Later Stage VC
  • (In Progress)

  • Investors
  • 15

Lumen Bioscience General Information

Description

Operator of a biosciences company intended to develop biologic drugs faster than traditional ways. The company's technology offers the potential to transform the biologics industry through increased speed, mass-market scale, and lower costs than current approaches and helps to discover, develop, and manufacture biologic drugs for several prevalent, worldwide diseases that currently lack any effective treatments, enabling clinicians to have therapeutics against disease targets that have been inaccessible to the biopharmaceutical industry.

Contact Information

Website
www.lumen.bio
Formerly Known As
Matrix Genetics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 1441 North 34th Street
  • Suite 300
  • Seattle, WA 98103
  • United States
+1 (206) 000-0000

Lumen Bioscience Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lumen Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 15-Sep-2023 0000 In Progress Clinical Trials - Phase 2
9. Grant 01-Dec-2022 0000 0000 Completed Clinical Trials - Phase 2
8. Later Stage VC (Series C) 29-Jun-2022 0000 0000 Completed Clinical Trials - Phase 2
7. Grant 01-Jan-2021 0000 0000 Completed Clinical Trials - Phase 2
6. Grant 24-Sep-2020 000 0000 Completed Clinical Trials - Phase 2
5. Later Stage VC (Series B) 01-Sep-2020 000.00 0000 000.00 Completed Clinical Trials - Phase 2
4. Debt - PPP 10-Apr-2020 000.00 Completed Clinical Trials - Phase 2
3. Grant 01-Apr-2019 00.00 000.00 Completed Clinical Trials - Phase 2
2. Grant 17-May-2018 $2.8M $11.2M Completed Clinical Trials - Phase 2
1. Later Stage VC (Series A) 05-Aug-2017 $11.2M $11.2M 000.00 Completed Clinical Trials - Phase 2
To view Lumen Bioscience’s complete valuation and funding history, request access »

Lumen Bioscience Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Lumen Bioscience’s complete cap table history, request access »

Lumen Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biosciences company intended to develop biologic drugs faster than traditional ways. The company's technol
Drug Discovery
Seattle, WA
67 As of 2023
0000
0000000000 0 0000

000000

do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
0000 000000000
Shenzhen, China
0000 As of 0000
00000
0.000 0000-00-00
00000000000 00000

00000

rehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excep
0000000000000
Cambridge, MA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lumen Bioscience Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
XtalPi Technology Venture Capital-Backed Shenzhen, China 0000 00000 00000000000 00000
00000 000000000000 Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
00000 (0000 000000 Formerly VC-backed Somerville, MA 00 00000 00000000 00000
00000 Formerly VC-backed Vancouver, WA 000 00000 00000000 00000
00000000 000000000 Private Equity-Backed Stockholm, Sweden 000 000.00 00000000000
You’re viewing 5 of 9 competitors. Get the full list »

Lumen Bioscience Patents

  • 51

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 4

    Granted

  • 3

    Pending

  • 000

    Expiring in next 12 mo

Lumen Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3143735-A1 Arthrospira platensis non-parenteral therapeutic delivery platform Pending 03-Jul-2019 0000000000
EP-3994152-A1 Arthrospira platensis non-parenteral therapeutic delivery platform Pending 03-Jul-2019 0000000000
US-20210338751-A1 Arthrospira platensis non-parenteral therapeutic delivery platform Pending 03-Jul-2019 0000000000 0
AU-2020298626-A1 Arthrospira platensis non-parenteral therapeutic delivery platform Pending 03-Jul-2019 00000000
EP-3994152-A4 Arthrospira platensis non-parenteral therapeutic delivery platform Pending 03-Jul-2019 C12N1/20 0
To view Lumen Bioscience’s complete patent history, request access »

Lumen Bioscience Executive Team (7)

Name Title Board Seat Contact Info
Brian Finrow JD Co-Founder, Chief Executive Officer & Board Member
Don Schlosser Co-Chief Financial Officer & Advisor
Eric Orse Co-Chief Financial Officer
James Roberts Ph.D Co-Founder, Chief Scientific Officer & Board Member
You’re viewing 4 of 7 executive team members. Get the full list »

Lumen Bioscience Board Members (11)

Name Representing Role Since
Brian Finrow JD Lumen Bioscience Co-Founder, Chief Executive Officer & Board Member 000 0000
Edward Schlect Avista (US) Board Observer 000 0000
Erik Anderson WestRiver Group Board Member 000 0000
James Roberts Ph.D Lumen Bioscience Co-Founder, Chief Scientific Officer & Board Member 000 0000
Marcos Milla Ph.D Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Lumen Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lumen Bioscience Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Biomedical Advanced Research and Development Authority Government 000 0000 000000 0
Foundation for Food and Agriculture Research Government 000 0000 000000 0
Naval Medical Research Center Government 000 0000 000000 0
Medical Technology Enterprise Consortium Government 000 0000 000000 0
United States Department of Agriculture Government 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

Lumen Bioscience Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 00000000 16-Jun-2021 00000 0000 Drug Discovery 00000 000
To view Lumen Bioscience’s complete investments history, request access »

Ready to get started?

Request a free trial